NeuroMetrix Inc (NURO) - Medical Equipment - Deals and Alliances Profile
October 2018
49
About the Report
About the Report
Summary
NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company's products include quell wearable pain relief device, quell health cloud, DPNCheck point-of-care neuropathy test and advance system. Its DPNCheck is used for the treatment of diabetic peripheral neuropathy. NeuroMetrix offers services in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company serves clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through its network of distributors in Americas, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.
NeuroMetrix Inc (NURO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
NeuroMetrix Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NeuroMetrix Inc, Medical Equipment, Deal Details 11
Partnerships 11
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 12
NeuroMetrix Enters into Agreement with Synovation Medical 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 17
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 18
Equity Offering 19
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 19
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 21
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 22
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 24
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 27
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 29
NeuroMetrix Raises USD8 Million in Private Placement of Securities 31
NeuroMetrix Completes Private Placement Of Preferred Shares For USD 5 Million 32
NeuroMetrix Completes Public Offering Of Units For USD 8.5 Million 33
Asset Transactions 34
GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix 34
NeuroMetrix Inc-Key Competitors 35
NeuroMetrix Inc-Key Employees 36
NeuroMetrix Inc-Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 37
Recent Developments 38
Financial Announcements 38
Jul 20, 2018: NeuroMetrix reports Q2 2018 financial results 38
Jan 25, 2018: NeuroMetrix Reports Q4 and Full Year 2017 Financial Results 39
Jan 08, 2018: NeuroMetrix Reports Preliminary 2017 Financial Highlights 40
Oct 19, 2017: NeuroMetrix Reports Q3 2017 Financial Results 41
Jul 20, 2017: NeuroMetrix Reports Q2 2017 Financial Results 42
Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results 43
Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results 44
Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016 45
Corporate Communications 46
Jul 06, 2017: NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics 46
Product News 47
Aug 28, 2018: NeuroMetrix reports presentation of clinical and scientific data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference 47
Apr 24, 2018: NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Figure
List of Figures
NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
NeuroMetrix Inc, Medical Equipment, Key Facts, 2017 2
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Deals By Market, 2012 to YTD 2018 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 12
NeuroMetrix Enters into Agreement with Synovation Medical 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 17
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 18
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 19
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 21
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 22
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 24
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 27
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 29
NeuroMetrix Raises USD8 Million in Private Placement of Securities 31
NeuroMetrix Completes Private Placement Of Preferred Shares For USD 5 Million 32
NeuroMetrix Completes Public Offering Of Units For USD 8.5 Million 33
GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix 34
NeuroMetrix Inc, Key Competitors 35
NeuroMetrix Inc, Key Employees 36
NeuroMetrix Inc, Joint Venture 37
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.